Delphia (Usa) Inc. Iovance Biotherapeutics, Inc. Transaction History

Delphia (Usa) Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$5.62 - $10.0 $34,866 - $62,040	-6,204 Reduced 36.95%	10,587 $67,000
Q3 2022 Nov 14, 2022	SELL	$9.53 - $13.11 $78,803 - $108,406	-8,269 Reduced 33.0%	16,791 $161,000
Q2 2022 Aug 15, 2022	BUY	$6.38 - $18.33 $51,040 - $146,640	8,000 Added 46.89%	25,060 $277,000
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $211,202 - $325,846	17,060 New	17,060 $284,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.35B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Delphia (Usa) Inc., based on Form 13F filings with the SEC.

Stay updated on Delphia (Usa) Inc. with notifications on news.